rs878853020
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The ENST00000361899.2(MT-ATP6):c.277A>G(p.Thr93Ala) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T93S) has been classified as Uncertain significance.
Frequency
Mitomap GenBank:
𝑓 0.00010 ( AC: 9 )
Consequence
MT-ATP6
ENST00000361899.2 missense
ENST00000361899.2 missense
Scores
Apogee2
Benign
Clinical Significance
No linked disesase in Mitomap
Conservation
PhyloP100: 7.09
Publications
2 publications found
Genes affected
MT-ATP6 (HGNC:7414): (mitochondrially encoded ATP synthase 6) Contributes to proton-transporting ATP synthase activity, rotational mechanism. Involved in mitochondrial ATP synthesis coupled proton transport. Part of mitochondrial proton-transporting ATP synthase complex. Implicated in Leber hereditary optic neuropathy; NARP syndrome; Parkinson's disease; multiple sclerosis; and systemic lupus erythematosus. [provided by Alliance of Genome Resources, Apr 2022]
MT-ATP8 (HGNC:7415): (mitochondrially encoded ATP synthase 8) Contributes to proton-transporting ATP synthase activity, rotational mechanism. Involved in mitochondrial ATP synthesis coupled proton transport. Part of mitochondrial proton-transporting ATP synthase complex. Implicated in multiple sclerosis and urinary bladder cancer. [provided by Alliance of Genome Resources, Apr 2022]
MT-ATP8 Gene-Disease associations (from GenCC):
- mitochondrial proton-transporting ATP synthase complex deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- periodic paralysis with later-onset distal motor neuropathyInheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial diseaseInheritance: AR, Mitochondrial Classification: LIMITED Submitted by: Illumina, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Apogee2 supports a benign effect, 0.09584203 < 0.5 .
BP6
Variant M-8803-A-G is Benign according to our data. Variant chrM-8803-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 692989.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomadMitoHomoplasmic at 26
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000361899.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
There are no transcript annotations for this variant. | |||||||||
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MT-ATP6 | ENST00000361899.2 | TSL:6 | c.277A>G | p.Thr93Ala | missense | Exon 1 of 1 | ENSP00000354632.2 | P00846 | |
| MT-ATP8 | ENST00000361851.1 | TSL:6 | c.*231A>G | downstream_gene | N/A | ENSP00000355265.1 | P03928 |
Frequencies
Mitomap GenBank
AF:
AC:
9
Gnomad homoplasmic
AF:
AC:
26
AN:
56433
Gnomad heteroplasmic
AF:
AC:
0
AN:
56433
Mitomap
No disease associated.
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Likely benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
Leigh syndrome (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
Hmtvar
Pathogenic
AlphaMissense
Benign
BayesDel_addAF
Benign
T
DEOGEN2
Benign
T
LIST_S2
Benign
T
MutationAssessor
Pathogenic
H
PhyloP100
PROVEAN
Uncertain
D
Sift4G
Uncertain
D
GERP RS
Varity_R
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.